Genasys GNSS Q1 2026 Earnings EPS 002 Beats Estimates Enterprise EFSCP Declines 051 Amid Market Weakness 20260515 Artivion AORT Rallies 065 as Bulls Target 2423 20260515 UK Cracks Down on Driving Test Bot Resellers Amid Soaring Costs New Laws to Block Inflated Prices Kevin Warsh Set to Be Sworn In as Federal Reserve Chair This Friday at White House Ceremony Shoals SHLS Reports Strong Q1 2026 Revenue NA EPS Beats Analyst Report on Charles Schwab Market Implications and Investor Considerations LG Display LPL Q4 2025 Earnings Massive EPS Miss Amid Unexplained Stock Rally Intel Pushes PC Makers Toward 18A Chips as AI Demand Surges Margin Boost Potential Foresight Ventures Backs PopDEX with 30M Investment in Perpetual DEX Innovation Morgan Stanley Boosts Aflac Price Target to 125 on Insurance Strength Wealthy Couple Pretends to Be Strapped for Cash to Fit In The Social Cost of Financial Disguise Companies Continue Betting on Prediction Markets Amid Regulatory Uncertainty China Urges APEC Cooperation as Commerce Minister Skips Meeting Due to Urgent Business SSL Q1 2026 Earnings Modest EPS Beat Amidst Operational Discipline 374Water Inc SCWO Q1 2026 Earnings Net Loss Widens as Development Continues Without Revenue AZZ Inc Q1 2026 Earnings EPS Surpasses Estimates on Strong Operational Execution Iveda Solutions IVDA Q2 2024 Earnings Narrower Loss Beats Expectations Despite Revenue Uncertainty HOOD Q1 2026 Earnings EPS Misses Estimates Amid Revenue Uncertainty Shares Edge Higher Bank of Marin Bancorp BMRC Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Landscape Coeptis Therapeutics Warrants COEPW Hover at 001 in Stagnant Trading Environment Cencora Inc COR Holds Steady Near Support as Neutral Trading Continues PennantPark Floating Rate Capital PFLT Edges Higher Amid Stable Trading Volume Kelly Services KELYA Surges 374 Testing Resistance After Breaking Above Support KVAC Holds Steady Near Midpoint as SPAC Investors Weigh Next Move SpaceX Postpones Starship Launch Amid Anticipated Mega Share Sale ADXN Q1 2024 Earnings EPS Reported at 1227 No Revenue as DevelopmentStage Biotech Continues STAK Inc STAK Holds Steady Near 096 as Bulls Test Resistance